找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Resistant Hypertension in Chronic Kidney Disease; Adrian Covic,Mehmet Kanbay,Edgar V. Lerma Book 2017 Springer International Publishing AG

[復制鏈接]
樓主: energy
11#
發(fā)表于 2025-3-23 10:15:59 | 只看該作者
Definition and Characteristics of Hypertension Associated with Chronic Kidney Disease: EpidemiologiCKD than in general population, and its frequency increases progressively with the severity of CKD varying in different CKD causes including renal artery stenosis (93%), diabetic nephropathy (87%), and polycystic kidney disease (74%). The pathogenesis of hypertension associated with chronic kidney d
12#
發(fā)表于 2025-3-23 15:11:51 | 只看該作者
13#
發(fā)表于 2025-3-23 19:38:31 | 只看該作者
14#
發(fā)表于 2025-3-24 01:56:13 | 只看該作者
15#
發(fā)表于 2025-3-24 02:35:33 | 只看該作者
Risk Stratification of Resistant Hypertension in Chronic Kidney Disease, pressure on optimal doses of three or more antihypertensive agents, ideally one being a diuretic. It causes cardiovascular and renal complications. RHTN may be a part of chronic kidney disease (CKD). RHTN diagnosis should be made early and treatment should be effective. Because it is a significant
16#
發(fā)表于 2025-3-24 07:35:08 | 只看該作者
17#
發(fā)表于 2025-3-24 14:09:48 | 只看該作者
Pathophysiological Insights of Hypertension in Patients with Chronic Kidney Disease,t organ for hypertension-induced damage. The association between hypertension and chronic kidney disease (CKD) is well known. The prevalence of hypertension increases and control of hypertension becomes more difficult as kidney functions decline. Understanding of the pathophysiology of hypertension
18#
發(fā)表于 2025-3-24 17:11:32 | 只看該作者
Secondary Causes: Work-Up and Its Specificities in CKD: Influence of Arterial Stiffening,ong time. Increased arterial stiffness is a major nontraditional cardiovascular risk factor in CKD reflecting the difficulty of the large arteries to convert flow oscillations into continuous blood flow due to significant morphological changes induced by this pathological condition. Surrogate marker
19#
發(fā)表于 2025-3-24 21:00:25 | 只看該作者
20#
發(fā)表于 2025-3-25 01:20:18 | 只看該作者
 關于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學 Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經(jīng)驗總結 SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學 Yale Uni. Stanford Uni.
QQ|Archiver|手機版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-12 20:25
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權所有 All rights reserved
快速回復 返回頂部 返回列表
濮阳市| 浑源县| 沐川县| 荃湾区| 中山市| 特克斯县| 丹阳市| 奉化市| 常宁市| 邓州市| 怀化市| 蒲城县| 建水县| 耒阳市| 富锦市| 莫力| 广安市| 文登市| 临朐县| 乌兰县| 建宁县| 精河县| 苍山县| 富源县| 栖霞市| 广元市| 康保县| 临邑县| 日土县| 恭城| 安图县| 广州市| 平塘县| 阿拉尔市| 灵丘县| 昌吉市| 克拉玛依市| 永清县| 任丘市| 灵台县| 遂昌县|